Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds

Author(s):  Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok

Issue:  Jan/Feb 2006 - Sports Medicine
View All Articles in Issue

Page(s):  74-78

Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 1
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 2
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 3
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 4
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 5

Download in electronic PDF format for $75

Abstract:  The objective of this study was to evaluate the stability of two phenytoin sodium suspensions in 0.9% sodium chloride solution for use in noninstitutional settings (where pharmacies are not present) to dispense phenytoin on a daily basis. A generic extended phenytoin sodium (Mylan) and a name brand phenytoin sodium (Dilantin) in suspension form were evaluated. Both suspensions were first assessed for degradation during frozen storage at designated time intervals. Frozen samples were compared with freshly prepared samples. The chemical stability of phenytoin concentrations in the samples was assessed by using a high-performance liquid chromatography analytical technique. During the course of the experiment, the samples showed no crystallization and the pH remained in a range of 10.6 to 10.73. The suspensions were tested for contamination. The results show that Dilantin and Mylan suspensions remained stable and free of contamination. Suspensions of phenytoin sodium in 0.9% sodium chloride solution are stable at room temperature for at least 2 weeks.

Related Keywords: phenytoin sodium, suspensions, topical preparation, wound healing, stability, pressure ulcers, decubitus ulcers

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, WOUND CARE, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Rhodes Richard S
, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
Jan/Feb 2006
Pg. 74-78

Options in Wound Care
Kincaid Michele R
Mar/Apr 2002
Pg. 92-95

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186

Phenytoin Sodium 20-mg/mL Topical Suspension
Allen Loyd V Jr
Jul/Aug 2007
Pg. 333

Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Muller George
, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
May/Jun 2009
Pg. 196-213

Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 282-285

Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Allen Loyd V Jr
Jul/Aug 2000
Pg. 301

Compounding with Sucralfate for the Treatment of External Wounds
Wynn Tom
, Williams LaVonn A
Jan/Feb 2009
Pg. 25-29

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
May/Jun 2003
Pg. 176-178

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 501-508

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Current Topical Treatments in Wound Healing - Part 2
Helmke Christopher D
Sep/Oct 2004
Pg. 354-357

Return to Top